PubHawk
JAMA April 2021 PMID 33755728

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial.

Domenica Rubino, Niclas Abrahamsson, Melanie Davies, Dan Hesse, Frank L Greenway, Camilla Jensen, Ildiko Lingvay, Ofri Mosenzon, Julio Rosenstock, Miguel A Rubio, Gottfried Rudofsky, Sayeh Tadayon, Thomas A Wadden, Dror Dicker

Download social card

Mentions

297
Peak: 71 in Mar 2021
across 8 sources since Mar 2021

Extended reach

3,130,660
potential audience

Total likes

2,226

Video views

174,120

Mentions per month

Mar 2021 – Oct 2026

Where it's discussed

  • X / Twitter175 posts
  • Facebook50 posts
  • Instagram49 posts
  • News12 articles
  • YouTube7 videos
  • LinkedIn2 posts
  • Bluesky1 posts
  • Reddit1 posts

AI synopsis

What people are saying

The collection shows a predominantly positive and curious discussion about STEP 4, with many posts highlighting that continuation of semaglutide leads to sustained weight loss while stopping leads to regain. Posts cite the magnitude of effects (e.g., continued weight loss around 7.9% vs regain ~6.9%), and several discuss policy, access, and broader implications. Language ranges from celebratory summaries to cautions about side effects and real-world applicability, reflecting diverse voices but a shared interest in the trial’s implications for obesity treatment and long-term management.

AgreementModerate agreement

Overall leaning toward acknowledging continued semaglutide benefits, with some skeptical or neutral notes in a subset of posts.

InterestHigh interest

High level of interest across languages and regions, frequent citations and calls to data.

EngagementModerate engagement

Many posts quote results or discuss mechanisms, but some are just sharing links or opinions without in-depth analysis.

ImpactModerate impact

Signals of moderate to high impact discussions, especially around continued use and weight regain after stopping.

Abstract in brief

  • The STEP 4 randomized clinical trial investigated the impact of continuing weekly semaglutide treatment compared to a placebo on weight loss maintenance in adults with overweight or obesity.
  • The study involved 902 participants and included a 20-week run-in period followed by 48 weeks where participants either continued semaglutide or switched to placebo, both with lifestyle intervention.
  • Results showed a mean weight loss percentage change from week 20 to week 68 of 7.9% for those continuing semaglutide versus 6.9% for the placebo group, indicating that continued treatment may be beneficial for maintaining weight loss.
Read the full abstract

Top posts

Most liked on X and Bluesky
Sato Shuntaro｜佐藤俊太朗
@Shuntarooo3 · X

このJAMA研究は下のNEJM研究よりも、論文・研究計画書・統計解析計画書を通して、Estimandの書き方がわかりやすい（サプリからとれます）。 Estimandを軸にした研究計画書になっている。SAPはEstimand除いてもシンプルでわかりやすい。まねしよう。 https://t.co/CgwEYrhdon

Dec 14, 2022 · 104 likes · 13 shares · 12,161 followers View post →
Carlos Morillas
@61Morillas · X

Nuevas evidencias de la eficacia de Semaglutide 2,4 mg en estudio STEP 4. Más cerca de su aprobación para personas con obesidad @sociedadSEEN @SociedadSeedo @SVEDYN_ https://t.co/yF2WdHakMP a través de @JAMA_current part of @JAMANetwork

Mar 27, 2021 · 55 likes · 17 shares · 2,620 followers View post →
Srđan Lukić
@srdjl · X

U prevodu, lek semaglutid je, kao uostalom i sve drugo što je učinkovito u mršavljenju, efikasan samo dok se primenjuje, ima odličan ali vremenski i procentualno ograničen učinak i kada se ukine dolazi do rebound efekta. Cela studija: https://t.co/BBGPDJcHXM

Feb 26, 2023 · 41 likes · 16,488 followers View post →
Jen Can NuSH
@JCanNuSH · X

https://t.co/i72EVYE71g

Jun 25, 2026 · 34 likes · 5 shares · 1,572 followers View post →
Dr Zoe Harcombe, PhD
@zoeharcombe · X

Refs: Drugs withdrawn: https://t.co/4mqMKuFbSh Lawsuits: https://t.co/phY9bYQQiR & death: https://t.co/pBPiAAO7QE Blog about Ozempic: https://t.co/eeE8gSGADp What happens when they're stopped: https://t.co/3D6jdpCnkT

Apr 27, 2024 · 33 likes · 13 shares · 224,423 followers View post →
Boback Ziaeian
@boback · X

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial ⁦@JAMA_current⁩ https://t.co/f78ymCNd0t

Mar 23, 2021 · 31 likes · 10 shares · 3,363 followers View post →

All mentions

Dr Abhijit Bhograj
@AiHealthDoc · X

https://t.co/shMwvkVmeY

Oct 21, 2026 · 373 followers View post →
Metabolic Nurse
@metabolicnurse · X

@peptidesgpt Worth adding the RCT anchor: STEP 4 (n=803) — after a 20-wk run-in (~10.6% lost), continuing semaglutide gave another −7.9% by wk 68; switching to placebo gave +6.9% regain. Regain on stopping is expected pharmacology. https://t.co/2s7G0CagSg

Sep 9, 2026 · 1 like · 3,378 followers View post →
Mark Kaplan
@markkaplan20 · X

9/ And the side effects. Look at this chart. 44% of users report nausea. 30% diarrhea. 24% vomiting. 24% constipation. 20% abdominal pain. Up to 40% of the weight lost on Ozempic is muscle, not fat. That's where "Ozempic face" comes from. You're not just losing fat. You're losing https://t.co/gxDJP8OOpq

Jul 2, 2026 · 7 likes · 33,826 followers View post →
Jen Can NuSH
@JCanNuSH · X

https://t.co/i72EVYE71g

Jun 25, 2026 · 34 likes · 5 shares · 1,572 followers View post →
Grinto Davy
@smartphysio · X

https://t.co/Omiufj9OwI

May 6, 2026 · 411 followers View post →
Dr Dam Trevino
@drdaminternista · X

Ficha bibliográfica Rubino D, Abrahamsson N, Davies M, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity (STEP 4). JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224

May 3, 2026 View post →
TOMO@北の薬屋®
@kitanokusuriya · X

「間食」をやめた人で薬剤中止後もリバウンドなく経過された人はいました。 ◆過体重または肥満の成人における体重減少維持に対するセマグルチドの週1回皮下投与継続とプラセボとの比較 https://t.co/i6ACLtvwV8 https://t.co/vWeYvX62Ar

Jan 9, 2026 · 5 likes · 5,271 followers View post →
Dr Shailesh Singh
@drShaileshSingh · X

All the trials and studies i have talked about 1. Wadden TA, Bailey TS, Billings LK, Davies M, Frias JP, Koroleva A, et al. Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: The STEP

Dec 20, 2025 · 4 likes · 9,064 followers View post →
Central Alexisonfire Centro de Guarulhos
@leianesonfire.bsky.social · Bluesky

Eu acompanho alguns canais de divulgação científica e principalmente sobre alimentação e endocrinologia e eu gosto muito da Kamarada Luna, queria mais divulgadores abertamente de esquerda/marxistas youtu.be/egF6hPqPMjY?...

Oct 17, 2025 · 2 likes · 2 shares View post →
@MounjaroMusings
@MounjaroMusings · X

RT @BevTchangMD: University of Michigan @UMich imposes lifetime limits on #GLP1 access: https://t.co/gQMwxyqYve Bewildering when a well-re…

Sep 14, 2025 · 2 shares · 22 followers View post →
andres
@palacioendocrin · X

RT @BevTchangMD: University of Michigan @UMich imposes lifetime limits on #GLP1 access: https://t.co/gQMwxyqYve Bewildering when a well-re…

Sep 4, 2025 · 2 shares · 345 followers View post →
Beverly G. Tchang, MD
@BevTchangMD · X

University of Michigan @UMich imposes lifetime limits on #GLP1 access: https://t.co/gQMwxyqYve Bewildering when a well-respected academic institution implements policy precisely COUNTER to the scientific evidence (https://t.co/lvSjXCXOdX, https://t.co/pIjMlBFHxK) #obesity https://t.co/0vIlORxiFF

Sep 4, 2025 · 16 likes · 2 shares · 6,885 followers View post →
TexasBulldog
@Texas__Bulldog · X

@Davoricus @RandomMHumanoid @KeithMansfield @peterrhague Those switched to placebo after 20 weeks gained most of the weight back. https://t.co/MjlfbJOgoi https://t.co/7FcABzLIrB

Jul 5, 2025 · 2,760 followers View post →
GLP-1 Approved
@GLP1Approved · X

Credits: Alyssa Billingsley, PharmD - GoodRx Christina Aungst, PharmD - GoodRx https://t.co/ruyEQewXeA - Prescribing GLP-1 Receptor Agonists for Weight Loss: https://t.co/jhiJ6KfvVi - New study reveals why patients stop taking GLP-1 obesity drugs: https://t.co/owl2JtM0TQ -

Jun 24, 2025 · 9 likes · 497 followers View post →
Alan Roberts
@TheMFingCOO · X

https://t.co/2y2ZNiVmYA

Feb 11, 2025 · 2 likes · 48,473 followers View post →
ketozoe
@diamondgirlxxx · X

RT @zoeharcombe: Refs: Drugs withdrawn: https://t.co/4mqMKuFbSh Lawsuits: https://t.co/phY9bYQQiR & death: https://t.co/pBPiAAO7QE Blog…

Nov 9, 2024 · 14 shares · 359 followers View post →
Thomas Muriuki
@klenstert · X

RT @zoeharcombe: Refs: Drugs withdrawn: https://t.co/4mqMKuFbSh Lawsuits: https://t.co/phY9bYQQiR & death: https://t.co/pBPiAAO7QE Blog…

Nov 9, 2024 · 14 shares · 9,062 followers View post →
LindaYoung
@LindaYo72298445 · X

RT @zoeharcombe: Refs: Drugs withdrawn: https://t.co/4mqMKuFbSh Lawsuits: https://t.co/phY9bYQQiR & death: https://t.co/pBPiAAO7QE Blog…

Nov 9, 2024 · 14 shares · 5,562 followers View post →
マイコプラズマン@走る内科医：びわこマラソン2026
@Powerinves · X

@gwYXhEqd7kjpwYu ウゴービ・セマグルチドは中止後、それなりにリバウンドしてしまうのが難しい所。中断後の再使用なども今後増えそうです。 製薬会社としては儲かるからいいのかもしれませんが... https://t.co/qB6glUZ8wb https://t.co/dLTgsztAO1

Oct 30, 2024 · 3 likes · 977 followers View post →
مجموعة تكنوقراط مصر
@Eg_Technocrats · X

معلومة علي الماشي ?? ادويه انقاص الوزن الحديثه ما لها و ما عليها سيماجلوتايد (Semaglutide): يُباع تجاريًا باسم Wegovy وOzempic. يستخدم عادة لعلاج مرض السكري من النوع الثاني، لكنه يستخدم أيضًا لفقدان الوزن عن طريق زيادة الشعور بالشبع وتقليل تناول الطعام. موجنارو (Mounjaro): •

Oct 22, 2024 · 1 like · 1,152 followers View post →
чё за костёр тут?
@LOOKATSEV · X

@Slide_Gauge @fuck_kgb На самом деле STEP 4 исследования проводили до 68 недель использования, что как бы уже приличный срок. Куда уже больше? А самые первые лекарства вышли на рынок уже больше 10 лет назад, если бы что-то было, то давно вскрыли. https://t.co/pkkaoJ8EMH

Oct 20, 2024 · 2 likes · 638 followers View post →
Roots Community Health
@RootsEmpowers · X

Links Included in Briefing: Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes: https://t.co/rqX4giyteM Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: https://t.co/6mmrAYKPp7

Aug 6, 2024 · 1,639 followers View post →
ThatGirl74
@SpicySicilian74 · X

RT @zoeharcombe: Refs: Drugs withdrawn: https://t.co/4mqMKuFbSh Lawsuits: https://t.co/phY9bYQQiR & death: https://t.co/pBPiAAO7QE Blog…

May 4, 2024 · 14 shares · 2,666 followers View post →
Bryan Bargowski
@GosuGains · X

RT @zoeharcombe: Refs: Drugs withdrawn: https://t.co/4mqMKuFbSh Lawsuits: https://t.co/phY9bYQQiR & death: https://t.co/pBPiAAO7QE Blog…

Apr 27, 2024 · 14 shares · 2,734 followers View post →
KetoCN
@KetoCNOfficial · X

RT @zoeharcombe: Refs: Drugs withdrawn: https://t.co/4mqMKuFbSh Lawsuits: https://t.co/phY9bYQQiR & death: https://t.co/pBPiAAO7QE Blog…

Apr 27, 2024 · 14 shares · 45 followers View post →
Steve Cooksey
@diabeteswarrior · X

RT @zoeharcombe: Refs: Drugs withdrawn: https://t.co/4mqMKuFbSh Lawsuits: https://t.co/phY9bYQQiR & death: https://t.co/pBPiAAO7QE Blog…

Apr 27, 2024 · 14 shares · 7,793 followers View post →
I❤️ #Pennsylvania ,HEAVEN on
@LadyFrances1974 · X

RT @zoeharcombe: Refs: Drugs withdrawn: https://t.co/4mqMKuFbSh Lawsuits: https://t.co/phY9bYQQiR & death: https://t.co/pBPiAAO7QE Blog…

Apr 27, 2024 · 14 shares · 3,576 followers View post →
Sanj
@Mindzatwork · X

RT @zoeharcombe: Refs: Drugs withdrawn: https://t.co/4mqMKuFbSh Lawsuits: https://t.co/phY9bYQQiR & death: https://t.co/pBPiAAO7QE Blog…

Apr 27, 2024 · 14 shares · 1,651 followers View post →
Awakened Princess
@GastricpH · X

RT @zoeharcombe: Refs: Drugs withdrawn: https://t.co/4mqMKuFbSh Lawsuits: https://t.co/phY9bYQQiR & death: https://t.co/pBPiAAO7QE Blog…

Apr 27, 2024 · 14 shares · 1,010 followers View post →
Pandamonium
@PashaP300 · X

RT @zoeharcombe: Refs: Drugs withdrawn: https://t.co/4mqMKuFbSh Lawsuits: https://t.co/phY9bYQQiR & death: https://t.co/pBPiAAO7QE Blog…

Apr 27, 2024 · 14 shares · 84 followers View post →
Nick Papageorge
@NickPapageorge1 · X

RT @zoeharcombe: Refs: Drugs withdrawn: https://t.co/4mqMKuFbSh Lawsuits: https://t.co/phY9bYQQiR & death: https://t.co/pBPiAAO7QE Blog…

Apr 27, 2024 · 14 shares · 2,047 followers View post →
Paul Sumners
@sumnerdp · X

RT @zoeharcombe: Refs: Drugs withdrawn: https://t.co/4mqMKuFbSh Lawsuits: https://t.co/phY9bYQQiR & death: https://t.co/pBPiAAO7QE Blog…

Apr 27, 2024 · 14 shares · 771 followers View post →
Dr Zoe Harcombe, PhD
@zoeharcombe · X

Refs: Drugs withdrawn: https://t.co/4mqMKuFbSh Lawsuits: https://t.co/phY9bYQQiR & death: https://t.co/pBPiAAO7QE Blog about Ozempic: https://t.co/eeE8gSGADp What happens when they're stopped: https://t.co/3D6jdpCnkT

Apr 27, 2024 · 33 likes · 13 shares · 224,423 followers View post →
John Giacona, PhD, PA-C
@GiaconaJohn · X

RT @CRoeAPRN: Session of the day at #ACC24 @ACCinTouch for me was "Balancing the Scale" on anti-obesity drugs. Key point: Continue after pa…

Apr 6, 2024 · 1 share · 600 followers View post →
Christopher Roe
@CRoeAPRN · X

Session of the day at #ACC24 @ACCinTouch for me was "Balancing the Scale" on anti-obesity drugs. Key point: Continue after patients reach their goal--similar to how we manage blood pressure and lipids. #ACCCVT #ACCMember Rubino, et al. (2021) JAMA doi:10.1001/jama.2021.3224 https://t.co/MRJLilOZWk

Apr 6, 2024 · 2 likes · 1 share · 36 followers View post →
burnoutinho
@burnoutinho · X

@eeagorajose @malu_maderfc ta no material suplementar do STEP1 uma proporção de 41% de perda de massa magra em relação a gordura 800 pacientes que atingiram dose máxima https://t.co/GXaz6Qy1g8

Mar 26, 2024 · 6 likes · 11,885 followers View post →
Kate Manne
@kate_manne · X

@IonaItalia https://t.co/NuiMSMUl6O

Jan 8, 2024 · 45,399 followers View post →
TheGreenDjinn
@djinn_the · X

@Intimacyenergy @alxoh0lic @danishacarterr Here are a few https://t.co/AQWo9nAGfi https://t.co/SUsDaVKU67 https://t.co/xHvkausmEo https://t.co/6lESN9yIMP https://t.co/x6GjXPuO7U

Jan 1, 2024 · 5 likes · 1,629 followers View post →
gamechanger2020xz
@gamechanger2022 · X

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight ... https://t.co/U5ybgj0VJ4

Nov 21, 2023 · 14 followers View post →
Nick Tiller, Ph.D.
@NBTiller · X

And because drugs alone don't help people change their relationships with food or develop healthy, sustainable dietary patterns, people quickly regain weight as soon as they stop the treatment. 3/5

Jun 12, 2023 · 2 likes · 10,657 followers View post →
Kevin Hall
@KevinH_PhD · X

What happens if instead stopping the intervention people are switched from semaglutide to placebo? This was studied in the STEP 4 trial & simulated below in the dashed curve (those continuing the drug are in solid curves). https://t.co/lC9ygwXEVf https://t.co/9ax1pnPTFu

May 3, 2023 · 20 likes · 1 share · 38,085 followers View post →
Ben Celis
@celis_ben · X

RT @HoeyberghsJeff: Het effect van het nieuwe vermager-medicijn SEMAGLUTIDE is averechts wanneer gestopt en bescheiden wanneer men er mee d…

Mar 11, 2023 · 4 shares · 1,649 followers View post →
Kylo Ren
@ddfa3434 · X

RT @HoeyberghsJeff: Het effect van het nieuwe vermager-medicijn SEMAGLUTIDE is averechts wanneer gestopt en bescheiden wanneer men er mee d…

Mar 10, 2023 · 4 shares · 490 followers View post →
Nadia
@Naadieake · X

RT @HoeyberghsJeff: Het effect van het nieuwe vermager-medicijn SEMAGLUTIDE is averechts wanneer gestopt en bescheiden wanneer men er mee d…

Mar 10, 2023 · 4 shares · 406 followers View post →
Ceragioli Maxime
@CeragioliMaxime · X

RT @HoeyberghsJeff: Het effect van het nieuwe vermager-medicijn SEMAGLUTIDE is averechts wanneer gestopt en bescheiden wanneer men er mee d…

Mar 9, 2023 · 4 shares · 208 followers View post →
Jeff Hoeyberghs
@HoeyberghsJeff · X

Het effect van het nieuwe vermager-medicijn SEMAGLUTIDE is averechts wanneer gestopt en bescheiden wanneer men er mee doorgaat. "With continued semaglutide, mean body weight change from week 20 to week 68 was −7.9% vs +6.9% with the switch to placebo" https://t.co/TmyX1qNSQT

Mar 9, 2023 · 7 likes · 4 shares · 25,062 followers View post →
Jacob Eliosoff
@JaEsf · X

@AlecStapp This is my favorite: check out the results if they are vs aren't switched to a placebo midway through. Persuasive stuff! https://t.co/qUTrF9OSpe https://t.co/RC9yO3RQKQ

Mar 2, 2023 · 2 likes · 4,287 followers View post →
Srđan Lukić
@srdjl · X

U prevodu, lek semaglutid je, kao uostalom i sve drugo što je učinkovito u mršavljenju, efikasan samo dok se primenjuje, ima odličan ali vremenski i procentualno ograničen učinak i kada se ukine dolazi do rebound efekta. Cela studija: https://t.co/BBGPDJcHXM

Feb 26, 2023 · 41 likes · 16,488 followers View post →
Ryu Blockchain HODL
@ryudai94 · X

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity The STEP 4 Randomized Clinical Trial　https://t.co/HmMYO4uq5S

Feb 12, 2023 · 1 like · 869 followers View post →
Adi Nadimpalli
@Adi504 · X

Now that's a disclosure statement! With this...do we even need to read this study? https://t.co/ZdOdQTirL1 https://t.co/rqw6OQSH3C

Jan 28, 2023 · 224 followers View post →
schist
@SpiritOfEnterpr · X

@OverSaltPretzel @DrNadolsky No one real isn't recommending exercise, for anyone, it's good regardless of weight. Semaglutide (Wegovy) works like mind blowingly well, and it's sustained. Incredible stuff and an awesome tool for folks to use. The charts are always crazy looking. https://t.co/1oHfu3mLHT https://t.co/vLhbteFESu

Jan 8, 2023 · 1 like · 169 followers View post →
ひとし
@hitoshi11 · X

RT @Shuntarooo3: このJAMA研究は下のNEJM研究よりも、論文・研究計画書・統計解析計画書を通して、Estimandの書き方がわかりやすい（サプリからとれます）。 Estimandを軸にした研究計画書になっている。SAPはEstimand除いてもシンプルでわか…

Dec 15, 2022 · 13 shares · 1,404 followers View post →
再エネマスコット“ふぅくん”
@Fuukun_Kazenoko · X

RT @Shuntarooo3: このJAMA研究は下のNEJM研究よりも、論文・研究計画書・統計解析計画書を通して、Estimandの書き方がわかりやすい（サプリからとれます）。 Estimandを軸にした研究計画書になっている。SAPはEstimand除いてもシンプルでわか…

Dec 15, 2022 · 13 shares · 106 followers View post →
風船
@S87ynAgVLsfjyDw · X

RT @Shuntarooo3: このJAMA研究は下のNEJM研究よりも、論文・研究計画書・統計解析計画書を通して、Estimandの書き方がわかりやすい（サプリからとれます）。 Estimandを軸にした研究計画書になっている。SAPはEstimand除いてもシンプルでわか…

Dec 15, 2022 · 13 shares · 3 followers View post →
やま ぐち
@naoking105 · X

RT @Shuntarooo3: このJAMA研究は下のNEJM研究よりも、論文・研究計画書・統計解析計画書を通して、Estimandの書き方がわかりやすい（サプリからとれます）。 Estimandを軸にした研究計画書になっている。SAPはEstimand除いてもシンプルでわか…

Dec 15, 2022 · 13 shares · 276 followers View post →
ysaito
@ysaito8015 · X

RT @Shuntarooo3: このJAMA研究は下のNEJM研究よりも、論文・研究計画書・統計解析計画書を通して、Estimandの書き方がわかりやすい（サプリからとれます）。 Estimandを軸にした研究計画書になっている。SAPはEstimand除いてもシンプルでわか…

Dec 15, 2022 · 13 shares · 2,752 followers View post →
おれんじ色
@orangeiro7 · X

RT @Shuntarooo3: このJAMA研究は下のNEJM研究よりも、論文・研究計画書・統計解析計画書を通して、Estimandの書き方がわかりやすい（サプリからとれます）。 Estimandを軸にした研究計画書になっている。SAPはEstimand除いてもシンプルでわか…

Dec 14, 2022 · 13 shares · 1,802 followers View post →
塚越大智 / Daichi Tsukakoshi
@tsukakoshi_ot · X

RT @Shuntarooo3: このJAMA研究は下のNEJM研究よりも、論文・研究計画書・統計解析計画書を通して、Estimandの書き方がわかりやすい（サプリからとれます）。 Estimandを軸にした研究計画書になっている。SAPはEstimand除いてもシンプルでわか…

Dec 14, 2022 · 13 shares · 1,689 followers View post →
CARAN R
@r_caran · X

RT @Shuntarooo3: このJAMA研究は下のNEJM研究よりも、論文・研究計画書・統計解析計画書を通して、Estimandの書き方がわかりやすい（サプリからとれます）。 Estimandを軸にした研究計画書になっている。SAPはEstimand除いてもシンプルでわか…

Dec 14, 2022 · 13 shares · 119 followers View post →
kokako
@kokako65541706 · X

RT @Shuntarooo3: このJAMA研究は下のNEJM研究よりも、論文・研究計画書・統計解析計画書を通して、Estimandの書き方がわかりやすい（サプリからとれます）。 Estimandを軸にした研究計画書になっている。SAPはEstimand除いてもシンプルでわか…

Dec 14, 2022 · 13 shares · 6 followers View post →
tsubameuni
@fjge3dkgutcka · X

RT @Shuntarooo3: このJAMA研究は下のNEJM研究よりも、論文・研究計画書・統計解析計画書を通して、Estimandの書き方がわかりやすい（サプリからとれます）。 Estimandを軸にした研究計画書になっている。SAPはEstimand除いてもシンプルでわか…

Dec 14, 2022 · 13 shares · 40 followers View post →
沼Utsubo@Kummerspeck
@epsilonminder · X

RT @Shuntarooo3: このJAMA研究は下のNEJM研究よりも、論文・研究計画書・統計解析計画書を通して、Estimandの書き方がわかりやすい（サプリからとれます）。 Estimandを軸にした研究計画書になっている。SAPはEstimand除いてもシンプルでわか…

Dec 14, 2022 · 13 shares · 579 followers View post →
Sato Shuntaro｜佐藤俊太朗
@Shuntarooo3 · X

このJAMA研究は下のNEJM研究よりも、論文・研究計画書・統計解析計画書を通して、Estimandの書き方がわかりやすい（サプリからとれます）。 Estimandを軸にした研究計画書になっている。SAPはEstimand除いてもシンプルでわかりやすい。まねしよう。 https://t.co/CgwEYrhdon

Dec 14, 2022 · 104 likes · 13 shares · 12,161 followers View post →
Beverly G. Tchang, MD
@BevTchangMD · X

@JimJohnsonSci @CateVarney @ArianaMChao @elonmusk Not for primary prevention but there are trials looking at a related question of prevention of weight regain. Eg) https://t.co/PqQ1koKKjg

Oct 23, 2022 · 2 likes · 6,117 followers View post →
Andy Grannell
@Grannell_ · X

Within the document they state long term data is not there yet so this impacts on analysis of cost effectiveness. Yet we have data that shows stopping the medication leads to regain. https://t.co/oyh3XxJmrN

Jun 18, 2022 · 4 likes · 985 followers View post →
Ed Cara
@EdCara4 · X

@JimJohnsonSci @StephenORahilly @DanielJDrucker There is post-treatment data from the pivotal trials of Wegovy, and a separate discontinuation arm, both of which found substantial but not complete weight regain within a few months. https://t.co/NnI2tQNbe8

Feb 9, 2022 · 1 like · 2,895 followers View post →
Filip K. Knop
@Filip_Knop · X

@TamarHaspel This is what happened after discontinuation in STEP4, i.e., in a setting involving lifestyle intervention. Less sharply ascending curve... Full paper here: https://t.co/AbRJb0Vrut https://t.co/448L8sQhB2

Feb 9, 2022 · 1 like · 2,516 followers View post →
Kevin Hall
@KevinH_PhD · X

@JimJohnsonSci @StephenORahilly @DanielJDrucker https://t.co/lC9ygxffMN https://t.co/8sMz5P7ZX3

Feb 9, 2022 · 3 likes · 38,085 followers View post →
Stephan J. Guyenet
@sguyenet · X

@RomanRussy @DavidMacklinMD I think it's a fair question. I don't have granular info on this but the STEP-1 and STEP-4 semaglutide trials did report an aggregate measure of mental health and well-being, the SF-36 survey. The results favored semaglutide. https://t.co/uA7OeBidt6 https://t.co/5q6vc0pxpH

Oct 28, 2021 · 48,851 followers View post →
猫になりたい薬剤師
@Vannyamoto · X

https://t.co/oYB8Pi6h1r

May 25, 2021 · 1,042 followers View post →
Melanie
@profmjdavies · X

RT @AmarPut: Other link https://t.co/NUUh7hW9YF

Apr 14, 2021 · 3 shares · 3,842 followers View post →
_aka13
@_aka13 · X

RT @JAMA_current: In this RCT, weekly subcutaneous #semaglutide resulted in increased weight loss over 48 weeks vs placebo in adults with #…

Apr 14, 2021 · 7 shares · 5 followers View post →
Add your name
@Nurazam_OMAR · X

RT @JAMA_current: In this RCT, weekly subcutaneous #semaglutide resulted in increased weight loss over 48 weeks vs placebo in adults with #…

Apr 14, 2021 · 7 shares · 77 followers View post →
BentButUnbowed
@davidallenN17 · X

RT @JAMA_current: In this RCT, weekly subcutaneous #semaglutide resulted in increased weight loss over 48 weeks vs placebo in adults with #…

Apr 14, 2021 · 7 shares · 1,319 followers View post →
BrownSkinGirl
@Lioness79457760 · X

RT @JAMA_current: In this RCT, weekly subcutaneous #semaglutide resulted in increased weight loss over 48 weeks vs placebo in adults with #…

Apr 14, 2021 · 7 shares · 600 followers View post →
Langdon
@langdon · X

RT @JAMA_current: In this RCT, weekly subcutaneous #semaglutide resulted in increased weight loss over 48 weeks vs placebo in adults with #…

Apr 14, 2021 · 7 shares · 173 followers View post →
Harold Henrison C. Chiu, MD, FPCP, FPCEDM (施君明醫師)
@88DoubleDragon · X

RT @JAMA_current: In this RCT, weekly subcutaneous #semaglutide resulted in increased weight loss over 48 weeks vs placebo in adults with #…

Apr 14, 2021 · 7 shares · 22,957 followers View post →
JAMA
@JAMA_current · X

In this RCT, weekly subcutaneous #semaglutide resulted in increased weight loss over 48 weeks vs placebo in adults with #overweight or #obesity https://t.co/tJECFXxWE8

Apr 14, 2021 · 20 likes · 7 shares · 488,143 followers View post →
Neil Floch MD
@NeilFlochMD · X

RT @AmarPut: Other link https://t.co/NUUh7hW9YF

Apr 13, 2021 · 3 shares · 130,075 followers View post →
Dr Amar Puttanna
@AmarPut · X

Other link https://t.co/NUUh7hW9YF

Apr 13, 2021 · 5 likes · 3 shares · 3,619 followers View post →
なちこ＠筋トレ
@nachipo · X

RT @takumasa39: 減量薬とされるセマグルチドの最終Step4試験についてのJAMAのRCT。 肥満患者を対象にセマグルチドを20週間投与し、その後、継続投与とプラセボに分け68週目の体重変化率を比較した結果、セマグルチド継続で有意な体重減少を認めたとのこと。 F…

Apr 13, 2021 · 8 shares · 7,936 followers View post →
しろりん
@shirorin00n · X

RT @takumasa39: 減量薬とされるセマグルチドの最終Step4試験についてのJAMAのRCT。 肥満患者を対象にセマグルチドを20週間投与し、その後、継続投与とプラセボに分け68週目の体重変化率を比較した結果、セマグルチド継続で有意な体重減少を認めたとのこと。 F…

Apr 13, 2021 · 8 shares · 151 followers View post →
第11回日本リハビリテーション栄養学術集会、リハ栄養
@rihaeiyou · X

RT @takumasa39: 減量薬とされるセマグルチドの最終Step4試験についてのJAMAのRCT。 肥満患者を対象にセマグルチドを20週間投与し、その後、継続投与とプラセボに分け68週目の体重変化率を比較した結果、セマグルチド継続で有意な体重減少を認めたとのこと。 F…

Apr 13, 2021 · 8 shares · 764 followers View post →
のほほん@ここから1歩
@run2runba · X

RT @takumasa39: 減量薬とされるセマグルチドの最終Step4試験についてのJAMAのRCT。 肥満患者を対象にセマグルチドを20週間投与し、その後、継続投与とプラセボに分け68週目の体重変化率を比較した結果、セマグルチド継続で有意な体重減少を認めたとのこと。 F…

Apr 13, 2021 · 8 shares · 708 followers View post →
若林秀隆 (Hidetaka Wakabayashi)
@HideWakabayashi · X

RT @takumasa39: 減量薬とされるセマグルチドの最終Step4試験についてのJAMAのRCT。 肥満患者を対象にセマグルチドを20週間投与し、その後、継続投与とプラセボに分け68週目の体重変化率を比較した結果、セマグルチド継続で有意な体重減少を認めたとのこと。 F…

Apr 13, 2021 · 8 shares · 15,170 followers View post →
PT
@lxrYlw8JxZ8497J · X

RT @takumasa39: 減量薬とされるセマグルチドの最終Step4試験についてのJAMAのRCT。 肥満患者を対象にセマグルチドを20週間投与し、その後、継続投与とプラセボに分け68週目の体重変化率を比較した結果、セマグルチド継続で有意な体重減少を認めたとのこと。 F…

Apr 13, 2021 · 8 shares · 9 followers View post →
僕酢（Egg_Protein）
@eldersister60 · X

RT @takumasa39: 減量薬とされるセマグルチドの最終Step4試験についてのJAMAのRCT。 肥満患者を対象にセマグルチドを20週間投与し、その後、継続投与とプラセボに分け68週目の体重変化率を比較した結果、セマグルチド継続で有意な体重減少を認めたとのこと。 F…

Apr 13, 2021 · 8 shares · 1,129 followers View post →
ひげおじさん彡
@nut_king_call · X

RT @takumasa39: 減量薬とされるセマグルチドの最終Step4試験についてのJAMAのRCT。 肥満患者を対象にセマグルチドを20週間投与し、その後、継続投与とプラセボに分け68週目の体重変化率を比較した結果、セマグルチド継続で有意な体重減少を認めたとのこと。 F…

Apr 13, 2021 · 8 shares · 326 followers View post →
庵野拓将 (Takumasa Anno)
@takumasa39 · X

減量薬とされるセマグルチドの最終Step4試験についてのJAMAのRCT。 肥満患者を対象にセマグルチドを20週間投与し、その後、継続投与とプラセボに分け68週目の体重変化率を比較した結果、セマグルチド継続で有意な体重減少を認めたとのこと。 FDAの承認に注目ですね。 https://t.co/OcnSqJWWlA

Apr 13, 2021 · 28 likes · 8 shares · 27,547 followers View post →
Alosa Health
@AlosaHealth · X

After a 20-week run-in period with weekly semiglutide injections (mean weight loss of 10.6%), those randomized to ongoing semiglutide had sustained weight loss over the next 48 weeks (-7.9% from week 20) compared to placebo (+6.9%). @JAMA_Current https://t.co/L9oUH7dJBP

Apr 12, 2021 · 253 followers View post →
Tom
@thedogdiet · X

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial https://t.co/WUBPxXlYXk

Apr 6, 2021 · 614 followers View post →
O. Ballesteros MD
@oswballesteros · X

RT @SABOURETCardio: Effect of Weekly #Semaglutide vs Placebo on Weight Loss Maintenance in #obesity https://t.co/9CoUvNC73W via @JAMA_curr…

Apr 6, 2021 · 5 shares · 668 followers View post →
Manuel Gaxiola
@cardiogax · X

RT @SABOURETCardio: Effect of Weekly #Semaglutide vs Placebo on Weight Loss Maintenance in #obesity https://t.co/9CoUvNC73W via @JAMA_curr…

Apr 6, 2021 · 5 shares · 7,990 followers View post →
| Daniel Sierra LM |
@DanielSierraLM · X

RT @SABOURETCardio: Effect of Weekly #Semaglutide vs Placebo on Weight Loss Maintenance in #obesity https://t.co/9CoUvNC73W via @JAMA_curr…

Apr 6, 2021 · 5 shares · 2,498 followers View post →
Dr.Md.Shahadat Hossain Khan
@WELOVEYOUALLAH1 · X

RT @SABOURETCardio: Effect of Weekly #Semaglutide vs Placebo on Weight Loss Maintenance in #obesity https://t.co/9CoUvNC73W via @JAMA_curr…

Apr 6, 2021 · 5 shares · 243 followers View post →
Lucile vigie
@LucileVigie · X

RT @SABOURETCardio: Effect of Weekly #Semaglutide vs Placebo on Weight Loss Maintenance in #obesity https://t.co/9CoUvNC73W via @JAMA_curr…

Apr 6, 2021 · 5 shares · 69 followers View post →
SABOURETCardiologist
@SABOURETCardio · X

Effect of Weekly #Semaglutide vs Placebo on Weight Loss Maintenance in #obesity https://t.co/9CoUvNC73W via @JAMA_current part of @JAMANetwork

Apr 6, 2021 · 16 likes · 5 shares · 31,098 followers View post →
JAMA Surgery
@JAMASurgery · X

In this RCT, weekly subcutaneous subcutaneous semaglutide resulted in increased weight loss over 48 weeks vs placebo in adults with #overweight or #obesity https://t.co/Fa1e1hBIgL

Apr 6, 2021 · 57,045 followers View post →
pity Saint James
@psantiagofernan · X

Será verdad q se haya encontrado el tratamiento de la obesidad? Effect of Weekly Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity https://t.co/QjKRs6thB8 vía @JAMA_current part of @JAMANetwork

Apr 5, 2021 · 441 followers View post →
Samar yousif
@Samaryous3 · X

RT @DrEenfeldt: As the recent NEJM study showed, GLP-1 once a week is a damn impressive weight-loss treatment. But of course, if you stop…

Apr 4, 2021 · 9 shares · 152 followers View post →
くりにかる3A5＠Ph.D.
@clinical89314 · X

Effect of Weekly Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity https://t.co/ssV90UKWix via @JAMA_current part of @JAMANetwork

Apr 3, 2021 · 1,284 followers View post →
Sawsan kurdi
@Sawsan_ · X

RT @accpambuprn: Obesity is a risk factor for many disease states and maintaining long-term weight loss is often a challenge for many. What…

Apr 2, 2021 · 3 shares · 1,363 followers View post →
Chapman University Pharmacy
@ChapmanPharmacy · X

RT @accpambuprn: Obesity is a risk factor for many disease states and maintaining long-term weight loss is often a challenge for many. What…

Apr 1, 2021 · 3 shares · 366 followers View post →
ACCP Ambulatory Care PRN
@accpambuprn · X

Obesity is a risk factor for many disease states and maintaining long-term weight loss is often a challenge for many. What are your thoughts on the use of semaglutide 2.4 mg weekly? Check out the STEP 4 trial which was recently published in #JAMA. https://t.co/0hUAn4A59e

Apr 1, 2021 · 16 likes · 3 shares · 2,929 followers View post →
Anna Maria Gilgen
@anna_gilgen · X

RT @CMichaelGibson: Among overweight adults who completed a 20-week run-in period with subcutaneous #semaglutide, 2.4 mg once weekly, maint…

Apr 1, 2021 · 12 shares · 638 followers View post →
Linda
@wordfinga · X

RT @CMichaelGibson: Among overweight adults who completed a 20-week run-in period with subcutaneous #semaglutide, 2.4 mg once weekly, maint…

Mar 31, 2021 · 12 shares · 4,594 followers View post →
Yeontan
@ZipBamBoomVoila · X

RT @jamecancerdoc: Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or O…

Mar 31, 2021 · 4 shares · 356 followers View post →
Raj Mehta
@raj_mehta · X

RT @CMichaelGibson: Among overweight adults who completed a 20-week run-in period with subcutaneous #semaglutide, 2.4 mg once weekly, maint…

Mar 30, 2021 · 12 shares · 2,133 followers View post →
Leonard Chiu, MD MS
@LeonardChiuMD · X

RT @CMichaelGibson: Among overweight adults who completed a 20-week run-in period with subcutaneous #semaglutide, 2.4 mg once weekly, maint…

Mar 30, 2021 · 12 shares · 5,749 followers View post →
Dr. Oriba Dan Langoya
@DrOribaDan · X

RT @CMichaelGibson: Among overweight adults who completed a 20-week run-in period with subcutaneous #semaglutide, 2.4 mg once weekly, maint…

Mar 30, 2021 · 12 shares · 22,963 followers View post →
Dr. Sue Gross
@DrSueGross · X

RT @CMichaelGibson: Among overweight adults who completed a 20-week run-in period with subcutaneous #semaglutide, 2.4 mg once weekly, maint…

Mar 30, 2021 · 12 shares · 3,030 followers View post →
Татьяна
@TatiSanti10 · X

RT @CMichaelGibson: Among overweight adults who completed a 20-week run-in period with subcutaneous #semaglutide, 2.4 mg once weekly, maint…

Mar 29, 2021 · 12 shares · 1,607 followers View post →
Ari Gattu
@GattuAri · X

RT @CMichaelGibson: Among overweight adults who completed a 20-week run-in period with subcutaneous #semaglutide, 2.4 mg once weekly, maint…

Mar 29, 2021 · 12 shares · 124 followers View post →
AngelaLoiza
@LoizaAngela · X

RT @CMichaelGibson: Among overweight adults who completed a 20-week run-in period with subcutaneous #semaglutide, 2.4 mg once weekly, maint…

Mar 29, 2021 · 12 shares · 17 followers View post →
hataboSAN
@hataboSAN · X

Effect of Weekly Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity https://t.co/4wp3oENRDb @JAMA_current part of @JAMANetworkより

Mar 29, 2021 · 997 followers View post →
Drdevi kalyan mishra
@KalyanDevi · X

RT @CMichaelGibson: Among overweight adults who completed a 20-week run-in period with subcutaneous #semaglutide, 2.4 mg once weekly, maint…

Mar 29, 2021 · 12 shares · 1,180 followers View post →
Harold Henrison C. Chiu, MD, FPCP, FPCEDM (施君明醫師)
@88DoubleDragon · X

RT @jamecancerdoc: Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or O…

Mar 29, 2021 · 4 shares · 22,957 followers View post →
Dr. Shashank Joshi
@AskDrShashank · X

RT @CMichaelGibson: Among overweight adults who completed a 20-week run-in period with subcutaneous #semaglutide, 2.4 mg once weekly, maint…

Mar 29, 2021 · 12 shares · 32,513 followers View post →
Muthu Vaduganathan
@mvaduganathan · X

RT @CMichaelGibson: Among overweight adults who completed a 20-week run-in period with subcutaneous #semaglutide, 2.4 mg once weekly, maint…

Mar 29, 2021 · 12 shares · 9,164 followers View post →
C. Michael Gibson MD
@CMichaelGibson · X

Among overweight adults who completed a 20-week run-in period with subcutaneous #semaglutide, 2.4 mg once weekly, maintaining treatment with semaglutide compared with switching to placebo resulted in continued weight loss over the following 48 weeks. https://t.co/HPd3lgdQIK

Mar 29, 2021 · 27 likes · 12 shares · 432,071 followers View post →
JAMA
@JAMA_current · X

RT @jamecancerdoc: Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or O…

Mar 29, 2021 · 4 shares · 488,143 followers View post →
andrea avila
@andrea_avilab · X

RT @EAPCPresident: Data from STEP 4 study show that 16 months of Semaglutide reduces body weight by almost 20%! It is far more effective th…

Mar 29, 2021 · 3 shares · 339 followers View post →
Dr. Shatha Samargandy
@DSamargandy · X

RT @DrEenfeldt: As the recent NEJM study showed, GLP-1 once a week is a damn impressive weight-loss treatment. But of course, if you stop…

Mar 29, 2021 · 9 shares · 4,927 followers View post →
JAMA Surgery
@JAMASurgery · X

RT @jamecancerdoc: Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or O…

Mar 29, 2021 · 4 shares · 57,045 followers View post →
@investigando
@rocatanho · X

En adultos con sobrepeso u obesidad que completan 20 sem con semaglutide subcutáneo 2.4 mg una vez por semana, mantener el tratamiento con semaglutide resultaría en una pérdida continua de peso durante 48 sem https://t.co/X74NZgchaC a través de @JAMA_current part of @JAMANetwork

Mar 29, 2021 · 400 followers View post →
Elad Maor
@maor_elad · X

RT @EAPCPresident: Data from STEP 4 study show that 16 months of Semaglutide reduces body weight by almost 20%! It is far more effective th…

Mar 29, 2021 · 3 shares · 3,185 followers View post →
EAPCPresident
@EAPCPresident · X

Data from STEP 4 study show that 16 months of Semaglutide reduces body weight by almost 20%! It is far more effective than placebo treatment. Read more here: https://t.co/JKP8ZZtYuI #EAPC_ESC #Cardiotwitter https://t.co/ynWISIe9F3

Mar 29, 2021 · 9 likes · 3 shares · 2,516 followers View post →
Public Health Bulletin
@BulletinPublic · X

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. https://t.co/5w7xVxFECL

Mar 28, 2021 · 19 followers View post →
うさたん
@88usagi · X

えと…こりは…ＤＭ専門医によって効果的な減量外来が始まるかもしれないということに繋がっていく話？ #よくわからないことは聞いてみる https://t.co/u3EmK0HQH5

Mar 28, 2021 · 1 like · 253 followers View post →
Ken Checicki
@KenChecicki · X

Continued weight loss with Semaglutide vs Placebo #weightloss #clinicalstudies #jama https://t.co/weTloQsv4L

Mar 28, 2021 · 73 followers View post →
Eduard Centeno
@segol60 · X

RT @alfonso_casi: En este ensayo clínico aleatorizado de adultos con sobrepeso u obesidad que completaron un período de preinclusión de 20…

Mar 28, 2021 · 1 share · 410 followers View post →
Salud juntos
@alfonso_casi · X

En este ensayo clínico aleatorizado de adultos con sobrepeso u obesidad que completaron un período de preinclusión de 20 semanas, el mantenimiento del tratamiento con semaglutida subcutánea obtiene una pérdida de peso continua respecto del cambio a placebo https://t.co/ih7pYPPf2C

Mar 28, 2021 · 1 share · 8,574 followers View post →
Jose C Souto, MD
@jcsouto · X

RT @DrEenfeldt: As the recent NEJM study showed, GLP-1 once a week is a damn impressive weight-loss treatment. But of course, if you stop…

Mar 27, 2021 · 9 shares · 14,595 followers View post →
Jame Abraham, MD, FACP
@jamecancerdoc · X

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial | ⁦@JAMA_current⁩ | ⁦⁦@JAMANetworkOpen⁩ https://t.co/DqTC05Gz5Y

Mar 27, 2021 · 12 likes · 4 shares · 12,246 followers View post →
Carlos Morillas
@61Morillas · X

Nuevas evidencias de la eficacia de Semaglutide 2,4 mg en estudio STEP 4. Más cerca de su aprobación para personas con obesidad @sociedadSEEN @SociedadSeedo @SVEDYN_ https://t.co/yF2WdHakMP a través de @JAMA_current part of @JAMANetwork

Mar 27, 2021 · 55 likes · 17 shares · 2,620 followers View post →
Doctora.Sharly
@sharly_martinez · X

RT @DrEenfeldt: As the recent NEJM study showed, GLP-1 once a week is a damn impressive weight-loss treatment. But of course, if you stop…

Mar 27, 2021 · 9 shares · 668 followers View post →
Katherine E. Paterson
@KEPatersonRD · X

RT @AbdTahrani: STEP 4: Continuation of Semaglutide 2.4mg weekly resulted in further weight loss (WL) vs stopping treatment causing weight…

Mar 27, 2021 · 9 shares · 700 followers View post →
Karlis Baltais
@karlisbaltais · X

RT @DrEenfeldt: As the recent NEJM study showed, GLP-1 once a week is a damn impressive weight-loss treatment. But of course, if you stop…

Mar 27, 2021 · 9 shares · 65 followers View post →
Tim Noakes
@ProfTimNoakes · X

RT @DrEenfeldt: As the recent NEJM study showed, GLP-1 once a week is a damn impressive weight-loss treatment. But of course, if you stop…

Mar 27, 2021 · 9 shares · 158,490 followers View post →
Austin Jeans
@jeansdoc61 · X

RT @DrEenfeldt: As the recent NEJM study showed, GLP-1 once a week is a damn impressive weight-loss treatment. But of course, if you stop…

Mar 27, 2021 · 9 shares · 964 followers View post →
Karageorgos
@Karageorgos15 · X

RT @DrEenfeldt: As the recent NEJM study showed, GLP-1 once a week is a damn impressive weight-loss treatment. But of course, if you stop…

Mar 27, 2021 · 9 shares · 611 followers View post →
DiscoStew
@DiscoStew66 · X

RT @DrEenfeldt: As the recent NEJM study showed, GLP-1 once a week is a damn impressive weight-loss treatment. But of course, if you stop…

Mar 27, 2021 · 9 shares · 10,798 followers View post →
Dr. E
@DrEenfeldt · X

As the recent NEJM study showed, GLP-1 once a week is a damn impressive weight-loss treatment. But of course, if you stop the drug the effect wears off and people regain weight, as shown in this new paper: https://t.co/4xKhufnC9f https://t.co/zeCIZtVszw

Mar 27, 2021 · 29 likes · 9 shares · 62,720 followers View post →
Dr Rahul D Barmanray
@RahulDBarmanray · X

Continuing semaglutide offers ongoing weight loss

Mar 27, 2021 · 2 likes · 378 followers View post →
pinacol
@pinacol · X

【RCT】糖尿病のない、BMIが30以上もしくは27以上で体重に関連した併存症が1つ以上あり、セマグルチドを20週投与後、維持量が2.4mg/週に達した成人へのその後のセマグルチド継続は、プラセボへの切り替えと比較して、体重減少率を増加させた。 #ペ読 https://t.co/DJZw7sPQzF

Mar 26, 2021 · 3 likes · 1,615 followers View post →
Last Week in Medicine
@lastweekinmed · X

In the STEP 4 trial of 803 overweight and obese people, those who were randomized to continue #semaglutide after 20 weeks of run-in for an additional 48 weeks had more weight loss than those who switched to placebo. #obesity @JAMANetwork #medtwitter https://t.co/meB5LyKWGx

Mar 26, 2021 · 1 like · 866 followers View post →
Gt.HTA y ECVSEMERGEN
@gt_hta · X

RT @josalar13: SETP-4:with semaglutide, weight change at 68 weeks - 8% vs +7% with placebo. @secardiologia @almucastro01 @domingomarzal @va…

Mar 26, 2021 · 3 shares · 1,005 followers View post →
Jacob Gudiol
@JacobGudiol · X

Mer imponerande resultat för GLP-1 agonister när det gäller viktnedgång Biverkningarna från den är medicinen är dock hyfsat stora men de flesta av deltagarna klarar uppenbarligen av det och väljer att fortsätta. Drygt 5% hoppade av pga biverkningar https://t.co/THULEyEmcB https://t.co/X0RYKTryjW

Mar 26, 2021 · 12 likes · 24,402 followers View post →
Sean C. Lucan, MD
@SeanLucan · X

maintaining treatment with #semaglutide compared with switching to placebo resulted in continued #weightloss. https://t.co/zjPMLB68Pf via @JAMA_current Great, re: subcutaneous. But what about the oral Form??? #obesity #medicine https://t.co/Dg8a6dGPdX

Mar 26, 2021 · 1 like · 1,498 followers View post →
Susana Monereo
@SusanaMonereo · X

RT @CristobMorales: https://t.co/urzOQAgNfn Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Ad…

Mar 25, 2021 · 13 shares · 2,217 followers View post →
the paper link
@the_paper_link · X

RT @the_paper_link: Trend new: Rubino D, ..., Step 4 Investigators (JAMA) __Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo…

Mar 24, 2021 · 1 share · 137 followers View post →
Sol
@ArualSogar · X

RT @CristobMorales: https://t.co/urzOQAgNfn Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Ad…

Mar 24, 2021 · 13 shares · 794 followers View post →
the paper link
@the_paper_link · X

Trend new: Rubino D, ..., Step 4 Investigators (JAMA) __Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial__ https://t.co/TVozZMVQvP

Mar 24, 2021 · 1 share · 137 followers View post →
Bhopender Thakur
@TheBhupiThakur · X

RT @DrKarlNadolsky: After completing a 20-week run-in period on semaglutide resulting over mean 10% weight loss, maintaining treatment with…

Mar 24, 2021 · 3 shares · 1,365 followers View post →
María Fernanda
@Mfamaris · X

RT @DrKarlNadolsky: After completing a 20-week run-in period on semaglutide resulting over mean 10% weight loss, maintaining treatment with…

Mar 24, 2021 · 3 shares · 98 followers View post →
Jasmin Levallois, MD
@jlevallois · X

RT @DrKarlNadolsky: After completing a 20-week run-in period on semaglutide resulting over mean 10% weight loss, maintaining treatment with…

Mar 24, 2021 · 3 shares · 1,357 followers View post →
Karl Nadolsky
@DrKarlNadolsky · X

After completing a 20-week run-in period on semaglutide resulting over mean 10% weight loss, maintaining treatment with subcutaneous semaglutide compared with switching to placebo resulted in continued weight loss. JAMA. online March 23, 2021. doi:10.1001/jama.2021.3224 https://t.co/d8otbM5fAf

Mar 24, 2021 · 17 likes · 3 shares · 5,860 followers View post →
SEEDO
@SociedadSeedo · X

RT @CristobMorales: https://t.co/urzOQAgNfn Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Ad…

Mar 24, 2021 · 13 shares · 10,558 followers View post →
MANUEL PALMEZANO
@manuelpalmezano · X

RT @CristobMorales: https://t.co/urzOQAgNfn Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Ad…

Mar 24, 2021 · 13 shares · 166 followers View post →
Juan Carlos Elizalde:.
@JuanElizalde777 · X

RT @CristobMorales: https://t.co/urzOQAgNfn Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Ad…

Mar 24, 2021 · 13 shares · 2,360 followers View post →
Ana Sanchez Bao
@ana_sanchez_bao · X

RT @CristobMorales: https://t.co/urzOQAgNfn Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Ad…

Mar 24, 2021 · 13 shares · 1,093 followers View post →
Cindy Manotas
@manotas_cindy · X

RT @boback: Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity:…

Mar 24, 2021 · 10 shares · 112 followers View post →
Jennifer Clements
@jclem1027 · X

RT @boback: Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity:…

Mar 23, 2021 · 10 shares · 248 followers View post →
Mneee3
@crafty8798 · X

RT @boback: Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity:…

Mar 23, 2021 · 10 shares · 291 followers View post →
Leslie Vargas-Ramírez
@lilo1278 · X

RT @boback: Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity:…

Mar 23, 2021 · 10 shares · 2,448 followers View post →
Julian mauricio Baez
@jbaez311 · X

RT @boback: Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity:…

Mar 23, 2021 · 10 shares · 28 followers View post →
Chiayu Chen, M.D.
@ChiayuChenMD · X

RT @boback: Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity:…

Mar 23, 2021 · 10 shares · 1,105 followers View post →
Boback Ziaeian
@boback · X

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial ⁦@JAMA_current⁩ https://t.co/f78ymCNd0t

Mar 23, 2021 · 31 likes · 10 shares · 3,363 followers View post →
Alejandra Fernández
@AleFer_endo · X

RT @CristobMorales: https://t.co/urzOQAgNfn Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Ad…

Mar 23, 2021 · 13 shares · 719 followers View post →
名前
@akkiii0830 · X

https://t.co/IutzadgzOi Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity The STEP 4 Randomized Clinical Trial

Mar 23, 2021 · 247 followers View post →
Sergio Hevia
@SerHevNav · X

RT @CristobMorales: https://t.co/urzOQAgNfn Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Ad…

Mar 23, 2021 · 13 shares · 723 followers View post →
redGDPS Diabetes
@redGDPS · X

RT @CristobMorales: https://t.co/urzOQAgNfn Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Ad…

Mar 23, 2021 · 13 shares · 15,498 followers View post →
Fco Carramiñana Barrera
@fcbzafra · X

RT @CristobMorales: https://t.co/urzOQAgNfn Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Ad…

Mar 23, 2021 · 13 shares · 2,744 followers View post →
Cristina Tejera
@cristinatejerap · X

RT @CristobMorales: https://t.co/urzOQAgNfn Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Ad…

Mar 23, 2021 · 13 shares · 11,473 followers View post →
SGENM
@SoGENM · X

RT @CristobMorales: https://t.co/urzOQAgNfn Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Ad…

Mar 23, 2021 · 13 shares · 552 followers View post →
Cristobal Morales
@CristobMorales · X

https://t.co/urzOQAgNfn Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity The STEP 4 Randomized Clinical Trial @SociedadSeedo @sociedadSEEN

Mar 23, 2021 · 14 likes · 13 shares · 17,049 followers View post →
Medicina Integrativa SABB Salud, Armonía, Bienestar y Belleza.
Facebook

JAMA. 2021;325(14): 1414-1425. doi:10.1001/jama.2021.3224 Shi Q, Wang Y, Hao Q, et al. Pharmacotherapy for adults with overweight and obesity: a systematic ...

Oct 24, 2026 View →
Dra. Claudia Ramos Torres | Guadalajara - Facebook
Facebook

Referencias: • STEP 4: doi:10.1001/jama.2021.3224. • SURMOUNT-4: doi:10.1001/jama.2023.24945. La investigación sobre estos medicamentos también busca ...

Oct 24, 2026 View →
Citius: Exercício, Nutrição e Resultado | Juiz de Fora MG - Facebook
Facebook

JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224 Locatelli JC, et al. Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize ...

Oct 24, 2026 View →
O peso baixou. Como estão seus treinos, sua alimentação e seu ...
Instagram

... , 2022 — STEP 1 (extensão). DOI: 10.1111/dom.14725. • Rubino et al., 2021 — STEP 4. DOI: 10.1001/jama.2021.3224.".

Oct 21, 2026 View →
A sua gordura tem memória, e é por isso que o peso volta. Hoje é ...
Instagram

JAMA. 2021;325(14):1414–1425. DOI: 10.1001/jama.2021.3224. 4 days ago · roberta_endocrino's profile picture. roberta_endocrino. •. Follow. AI ...

Oct 21, 2026 View →
Apa jadi bila berhenti ubat GLP-1? Ramai ingat berat akan kekal ...
Facebook

Rubino, D., et al. (2021). JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 ...

Oct 19, 2026 View →
Apa jadi bila berhenti ubat GLP-1? Ramai ingat berat ... - Facebook
Facebook

... JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 #wedotransformations #kurusfitonlinecoaching #misifightobesiti #coachnas ...

Oct 19, 2026 View →
Ozempic vs Gym: Who Loses More Fat After 6 Months? - Facebook
Facebook

https: //doi.org/10.1001/jama.2021.3224 4. Ghusn W et al. Weight loss outcomes with semaglutide. JAMA Netw Open. 2022. https://doi. org/10.1001/ ...

Oct 18, 2026 View →
Feito por Renato l Personal Trainer Dobrar o volume de treino faz o ...
Facebook

JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224 Locatelli JC, et al. Incretin-Based Weight Loss Pharmacotherapy: Can Resistance ...

Oct 15, 2026 View →
and it might just change how you think about weight loss forever ...
Facebook

JAMA, 325(14), 1414–1425. DOI: 10.1001/jama.2021.3224 Leidy HJ, Clifton PM, Astrup A, et al. (2015). The Role of Protein in Weight Loss and ...

Oct 14, 2026 View →
я стараюсь следить за всем, что выходит по GLP-1, потому что ...
Instagram

JAMA, 2021 doi.org/10.1001/jama.2021.3224 6. Тренировки и лираглутид (карточка 7) Jensen S.B.K. et al. Healthy weight loss maintenance with ...

Oct 12, 2026 View →
Parar a caneta emagrecedora sem acompanhamento pode ter ...
Instagram

JAMA. 2021;325(14):1414-25. doi:10.1001/jama.2021.3224. biancabuani. 4. Aronne LJ, Sattar N, Horn DB, et al. Continued treatment with ...

Oct 12, 2026 View →
how long does ozempic stay in your system? about 5 weeks per the ...
Instagram

References: Rubino et al., 2021 · DOI 10.1001/jama.2021.3224 (PMID 33755728) Wilding et al., 2022 · DOI 10.1111/dom ...

Oct 9, 2026 View →
T·Time Launches Cash-Pay Compounded GLP-1 and GIP
News

doi:10.1001/jama.2021.3224; Aronne LJ, et al. SURMOUNT-4. JAMA. 2024;331(1):38–48. doi:10.1001/jama.2023.24945; T·Time market comparison ...

Oct 9, 2026 View →
Comente LOTE aqui abaixo e receba o link para se inscrever no ...
Facebook

JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224 Locatelli JC, et al. Incretin-Based Weight Loss Pharmacotherapy: Can Resistance ...

Oct 9, 2026 View →
T·Time Launches Cash-Pay Compounded GLP-1 and GIP Injections ...
News

doi:10.1001/jama.2021.3224; Aronne LJ, et al. SURMOUNT-4. JAMA. 2024;331(1):38–48. doi:10.1001/jama.2023.24945; T·Time market comparison ...

Oct 9, 2026 View →
Comente LOTE aqui abaixo e receba o link para se inscrever no ...
Facebook

doi:10.1001/jama.2021.3224 Locatelli JC, et al. Incretin-Based ... Video Transcript: Aluno tá usando caneta emagrecedora precisa mesmo da ...

Oct 9, 2026 View →
comenta LOTE pra receber o link do congresso. Feito por Renato l ...
Facebook

JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224 Locatelli JC, et al. Incretin-Based Weight Loss Pharmacotherapy: Can Resistance ...

Oct 7, 2026 View →
A internet mostra os melhores resultados das canetas e, muitas ...
Instagram

JAMA. 2021;325(14):1414–1425. doi:10.1001/jama.2021.3224. sofiscardoso. Importante conhecer a fisiologia, a história da doenca. Seja ela ...

Oct 6, 2026 View →
La investigación sobre estos medicamentos también busca ...
Facebook

... la continuidad del tratamiento. Referencias: • STEP 4: doi:10.1001/jama.2021.3224. • SURMOUNT-4: doi:10.1001/jama.2023.24945. 4 · Like ...

Oct 5, 2026 View →
Emagrecer é uma coisa. Manter o peso perdido é outra. O estudo ...
Instagram

... JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224. #ObesidadeEmEvidência #Semaglutida #STEP4 #Obesidade ...

Oct 4, 2026 View →
**ยาลดน้ำหนักยุคใหม่ ลดได้ 15–25% จริงไหม?** คำตอบคือ ... - Facebook
Facebook

... 10.1001/jama.2021.3224** SURMOUNT-1 PMID **35658024** DOI **10.1056/NEJMoa2206038** SURMOUNT-4 PMID **38078870** PMCID **PMC10714284** DOI ...

Oct 4, 2026 View →
¿Bajaste de peso con Ozempic, Wegovy, Mounjaro o Zepbound y te ...
Facebook

JAMA. 2021;325:1414–1425. doi: 10.1001/jama.2021.3224 Aronne LJ, et al. JAMA. 2024;331:38–48. doi: 10.1001/jama.2023.24945 MENSAJE ANCLADO ...

Oct 1, 2026 View →
O QUE DIZEM OS ESTUDOS? STEP 1 — semaglutida Um ano após ...
Instagram

... .14725; STEP 4 — DOI 10.1001/jama.2021.3224; SURMOUNT-4 — DOI 10.1001/jama.2023.24945; Diretriz ABESO 2026, R12.".

Sep 30, 2026 View →
O que acontece quando a semaglutida é interrompida? O STEP 4 ...
Instagram

... JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224. #ObesidadeEmEvidência #Semaglutida #STEP4 #Obesidade #MedicinaBaseadaEmEvidências ...

Sep 27, 2026 View →
أوزمبك… معلومات مهمة لازم تعرفها قبل وأثناء الاستخدام احفظ البوست ...
Instagram

STEP 4 — JAMA, 2021. Rubino et al. DOI: 10.1001/jama.2021.3224. STEP 1 Trial Extension — Diabetes, Obesity and Metabolism, 2022. Wilding et al ...

Sep 27, 2026 View →
Price, Not Science, Drives Obesity GLP-1 Access: Holly Lofton, MD
News

... JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224; McCormick B. Gaps in persistence, coverage limit GLP-1 impact in obesity. AJMC ...

Sep 25, 2026 View →
As canetas emagrecedoras mudaram o tratamento da obesidade, e ...
Instagram

* JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224. #ObesidadeEmEvidência #Semaglutida #STEP4 #Obesidade ...

Sep 21, 2026 View →
Qual caneta emagrece mais é a pergunta que mais me chega, e ela ...
Instagram

JAMA. 2021;325(14):1414–1425. doi:10.1001/jama.2021.3224. sofiscardoso. Importante conhecer a fisiologia, a história da doenca. Seja ela ...

Sep 20, 2026 View →
Novo and Lilly to present at EASD 2026 on diabetes treatments
Facebook

2021;doi:10.1001/jama. 2021.3224. Wadden TA, et at. JAMA. 2021;doi:10.1002/jama. 2021.1831. Wilding JPH, et al. N Engl J Med. 2021;doi ...

Sep 16, 2026 View →
Semaglutide 2.4 mg & Chronic Weight Management | Dr. Daksh ...
Facebook

2021;doi:10.1001/jama. 2021.3224. Wadden TA, et at. JAMA. 2021;doi:10.1002/jama. 2021.1831. Wilding JPH, et al. N Engl J Med. 2021;doi ...

Sep 14, 2026 View →
A discussão sobre as “canetas” já passou da fase de ... - Instagram
Instagram

JAMA. 2021;325(14):1414–1425. doi:10.1001/jama.2021.3224. sofiscardoso. Importante conhecer a fisiologia, a história da doenca. Seja ela ...

Sep 13, 2026 View →
Has anyone been on a GLP-1? Is it dangerous? - Facebook
Facebook

JAMA. https://doi. org/10.1001/jama.2021.3224 (PMID: 33755728) European Medicines Agency (2023 review on GLP-1s) U.S. Food and Drug ...

Sep 8, 2026 View →
on new medical research and medications!! #medicine ... - Instagram
Instagram

JAMA. 2021;325(14):1414–1425. DOI: 10.1001/jama.2021.3224 #Ozempic #WeightLoss #ObesityCare #EvidenceBasedMedicine #HealthyLifestyle.

Sep 2, 2026 View →
Photos by Claudia Angarita (@claudiaangaritagomez) · August 30 ...
Instagram

JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224. Wilding, J. P. H., Batterham, R. L., Davies, M., et al. (2022). Weight ...

Aug 30, 2026 View →
Are you risking more than you gain with weight loss drugs? Discover ...
Instagram

JAMA. 2021;325(14):1414–1425. DOI: 10.1001/jama.2021.3224 #Ozempic #WeightLoss #ObesityCare #EvidenceBasedMedicine #HealthyLifestyle.

Aug 29, 2026 View →
DUH!!! - Instagram
Instagram

JAMA. 2021;325(14):1414–1425. DOI: 10.1001/jama.2021.3224 #Ozempic #WeightLoss #ObesityCare #EvidenceBasedMedicine #HealthyLifestyle.

Aug 28, 2026 View →
Lost the weight on Ozempic... now what? If you're thinking about ...
Instagram

JAMA. 2021;325(14):1414–1425. DOI: 10.1001/jama.2021.3224 #Ozempic #WeightLoss #ObesityCare #EvidenceBasedMedicine #HealthyLifestyle · August ...

Aug 26, 2026 View →
PIONEER 4 vs STEP 4: ambos estudiaron semaglutida… pero NO ...
Facebook

JAMA. 2021;325(14):1414-1425. DOI: 10.1001/jama. 2021.3224 #Semaglutida #PIONEER4 #STEP4 #Rybelsus #GLP1 Obesidad DiabetesTipo2 ...

Aug 21, 2026 View →
tras suspender glp1 como semaglutide o tirzepatide hay ... - Facebook
Facebook

JAMA. 2021;325(14):1414-1425. DOI: 10.1001/jama. 2021.3224 #Semaglutida #PIONEER4 #STEP4 #Rybelsus #GLP1 Obesidad DiabetesTipo2 ...

Aug 19, 2026 View →
Qué diferencia a Ozempic de Wegovy? A propósito de ... - Instagram
Instagram

doi:10.1001/jama.2021.3224. Aronne LJ, et al. JAMA. 2024;331:38–48. doi:10.1001/jama.2023.24945. View all 11 comments · dra.luisacalderon.

Aug 19, 2026 View →
What does new data say about the role of semaglutide in patients ...
Facebook

2021;doi:10.1001/jama. 2021.3224. Wadden TA, et at. JAMA. 2021;doi:10.1002/jama. 2021.1831. Wilding JPH, et al. N Engl J Med. 2021;doi ...

Aug 6, 2026 View →
What Is Qsymia—and Is It Right for You? If you're ... - Instagram
Instagram

JAMA. 2021;325(14):1414–1425. DOI: 10.1001/jama.2021.3224 #Ozempic #WeightLoss #ObesityCare #EvidenceBasedMedicine #HealthyLifestyle.

Aug 4, 2026 View →
¿Cuál es el mejor ejercicio para bajar de peso ... - Facebook
Facebook

JAMA. 2021;325(14):1414-1425. DOI: 10.1001/jama. 2021.3224 #Semaglutida #PIONEER4 #STEP4 #Rybelsus #GLP1 Obesidad DiabetesTipo2 ...

Aug 3, 2026 View →
Is Ozempic just the "easy way out" for weight loss? Not at ... - Instagram
Instagram

JAMA. 2021;325(14):1414–1425. DOI: 10.1001/jama.2021.3224 #Ozempic #WeightLoss #ObesityCare #EvidenceBasedMedicine #HealthyLifestyle · 3 اگست ...

Aug 3, 2026 View →
GLP-1 users are being made aware of the risks - Facebook
Facebook

JAMA. https://doi. org/10.1001/jama.2021.3224 (PMID: 33755728) European Medicines Agency (2023 review on GLP-1s) U.S. Food and Drug ...

Jul 31, 2026 View →
Manda “CONGRESSO” nos comentários pra receber o link do nosso ...
Facebook

JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224 Locatelli JC, et al. Incretin-Based Weight Loss Pharmacotherapy: Can Resistance ...

Jul 21, 2026 View →
How long does it take to lose weight on a GLP-1 drug? - Drugs.com
News

JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224; Son, A. J., et. al. 2026. Cycling GLP-1 receptor agonist treatment induces ...

Jul 21, 2026 View →
Around 10% to 15% of people struggle to lose weight on GLP-1 ...
Instagram

General information, not medical advice. References: Rubino et al., 2021 · DOI 10.1001/jama.2021.3224 (PMID 33755728) Wilding et al., 2022 · ...

Jul 19, 2026 View →
Despite substantial weight loss, most obesity drugs such as Wegovy ...
Facebook

2021;doi:10.1001/jama. 2021.3224. Wadden TA, et at. JAMA. 2021;doi:10.1002/jama. 2021.1831. Wilding JPH, et al. N Engl J Med. 2021;doi ...

Jul 9, 2026 View →
Interrompeu as canetas emagrecedoras? O peso pode ... - Instagram
Instagram

JAMA. 2021;325(14):1414–1425. DOI: 10.1001/jama.2021.3224. 6 days ago · uiaracintra's profile picture. uiaracintra. •. Follow. Photo by Uiara ...

Jun 20, 2026 View →
With the right plan and strong support, it's possible for some people ...
Facebook

Even if a GLP-1 medication is bringing someone's A1C down, they can still be insulin resistant. GLP-1s are helpful to an extent, but they don't ...

Jun 2, 2026 View →
O reels da semana trouxe uma notícia grande: a semaglutida ...
Instagram

... Maintenance in Adults With Overweight or Obesity (STEP 4). JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224".

May 11, 2026 View →
Vamos conversar sobre as “canetas emagrecedoras”? Os análogos ...
Instagram

... nutricionista: @nutrilemanacorda Referências (DOI): 10.1056/NEJMoa2032183 10.1056/NEJMoa2028395 10.1001/jama.2021.3224".

May 4, 2026 View →
What's been your experience as a patient or a clinician prescribing ...
Instagram

doi:10.1001/jama.2021.3224 2. Wilding JPH, et al. STEP 1 extension. Diabetes Obes Metab. 2022;24(8):1553–1564. doi: ...

Apr 25, 2026 View →
Aunque pertenecen a la misma familia (análogos de GLP-1), cada ...
Instagram

JAMA. 2021;325:1414–1425. doi:10.1001/jama.2021.3224. Aronne LJ, et al. JAMA. 2024;331:38–48. doi:10.1001/jama.2023.24945. View all 13 ...

Apr 17, 2026 View →
Yazen Health's Post - LinkedIn
LinkedIn

GLP-1 Drugs, Weight Loss And Muscle: What Are We Actually Measuring?

Apr 16, 2026 View →
Are you risking your health for quick weight loss ... - Instagram
Instagram

JAMA. 2021;325(14):1414–1425. DOI: 10.1001/jama.2021.3224 #Ozempic #WeightLoss #ObesityCare #EvidenceBasedMedicine #HealthyLifestyle.

Apr 9, 2026 View →
Citius: Exercício, Nutrição e Resultado - Facebook
Facebook

JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224 Locatelli JC, et al. Incretin-Based Weight Loss Pharmacotherapy: Can Resistance ...

Apr 6, 2026 View →
It was sold as appetite control. But appetite isn't isolated. It's tied to ...
Facebook

... JAMA. https://doi.org/10.1001/jama.2021.3224 (PMID: 33755728) European Medicines Agency (2023 review on GLP-1s) U.S. Food and Drug ...

Apr 6, 2026 View →
¿Estás en tratamiento con análogos de GLP-1? El verdadero ...
Instagram

JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224. Wilding, J. P. H., Batterham, R. L., Davies, M., et al. (2022). Weight ...

Apr 1, 2026 View →
Heard of Mounjaro and Ozempic, but unsure what sets them apart ...
Instagram

JAMA. 2021;325(14):1414–1425. DOI: 10.1001/jama.2021.3224 #Ozempic #WeightLoss #ObesityCare #EvidenceBasedMedicine #HealthyLifestyle · August ...

Mar 31, 2026 View →
La nueva SUSTANCIA? No es ni Ozempic… ni saxenda #peptides ...
Instagram

JAMA. 2021;325:1414–1425. doi:10.1001/jama.2021.3224. Aronne LJ, et al. JAMA. 2024;331:38–48. doi:10.1001/jama.2023.24945. View all 13 ...

Mar 31, 2026 View →
Evidence-based review of GLP-1 medications (Ozempic, Wegovy ...
Instagram

JAMA. 2021;325(14):1414–1425. DOI: 10.1001/jama.2021.3224 #Ozempic #WeightLoss #ObesityCare #EvidenceBasedMedicine #HealthyLifestyle · 8月3 ...

Mar 22, 2026 View →
#Entérate | Un estudio de la University of Cambridge señala que, un ...
Instagram

JAMA. 2021;325:1414–1425. doi:10.1001/jama.2021.3224. Aronne LJ, et al. JAMA. 2024;331:38–48. doi:10.1001/jama.2023.24945. View all 13 ...

Mar 5, 2026 View →
Nutricionista | Semaglutida (Ozempic, Wegovy, Rybelsus). Puede ...
Instagram

JAMA. 2021;325:1414–1425. doi:10.1001/jama.2021.3224. Aronne LJ, et al. JAMA. 2024;331:38–48. doi:10.1001/jama.2023.24945. View all 14 ...

Feb 12, 2026 View →
Are the Weight Loss Effects of Tirzepatide and Semaglutide ...
News

... JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224. Aronne LJ, Sattar N, Horn DB, et al. Continued treatment with tirzepatide for ...

Jan 29, 2026 View →
Before starting weight loss medications, make sure you consider all ...
Instagram

JAMA. 2021;325(14):1414–1425. DOI: 10.1001/jama.2021.3224 #Ozempic #WeightLoss #ObesityCare #EvidenceBasedMedicine #HealthyLifestyle.

Jan 15, 2026 View →
can a shot really replace healthy habits? Ozempic works ... - Instagram
Instagram

JAMA. 2021;325(14):1414–1425. DOI: 10.1001/jama.2021.3224 #Ozempic #WeightLoss #ObesityCare #EvidenceBasedMedicine #HealthyLifestyle · August ...

Jan 12, 2026 View →
Feito por @renato_bianchini Antes de mais nada, me conta uma ...
Facebook

JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224 Locatelli JC, et al. Incretin-Based Weight Loss Pharmacotherapy: Can Resistance ...

Jan 10, 2026 View →
Ozempic, Wegovy y otros inyectables se volvieron famosos porque ...
Instagram

2021.3224. Aronne LJ, et al. JAMA. 2024;331:38–48. doi:10.1001/jama.2023.24945.

Jan 8, 2026 View →
Ozempic doesn't have to drain your funds. Here's how to pay $25 or ...
Instagram

JAMA. 2021;325(14):1414–1425. DOI: 10.1001/jama.2021.3224 #Ozempic #WeightLoss #ObesityCare #EvidenceBasedMedicine #HealthyLifestyle · August ...

Dec 30, 2025 View →
Facial•Reductor•Botox•Fillers | Bajar de peso de forma segura sí es ...
Instagram

JAMA. 2021;325:1414–1425. doi:10.1001/jama.2021.3224. Aronne LJ, et al. JAMA. 2024;331:38–48. doi:10.1001/jama.2023.24945. View all 11 ...

Dec 12, 2025 View →
Ozempic (semaglutyd) podaje się raz w tygodniu: start 0,25 mg ...
Facebook

... JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 Chen, J., Zhang, Y., Zhao, Y., & Wang, Y. (2024). Long-term efficacy and ...

Dec 12, 2025 View →
El estudio CONFIDENCE confirma una disminución potente del ...
Facebook

JAMA. 2021;325(14):1414-1425. DOI: 10.1001/jama. 2021.3224 #Semaglutida #PIONEER4 #STEP4 #Rybelsus #GLP1 Obesidad DiabetesTipo2 ...

Nov 24, 2025 View →
Ozempic is a prescription medication—originally designed to help ...
Instagram

JAMA. 2021;325(14):1414–1425. DOI: 10.1001/jama.2021.3224 #Ozempic #WeightLoss #ObesityCare #EvidenceBasedMedicine #HealthyLifestyle · August ...

Nov 10, 2025 View →
How Long Does Ozempic Stay in Your System? This ... - Instagram
Instagram

JAMA. 2021;325(14):1414–1425. DOI: 10.1001/jama.2021.3224 #Ozempic #WeightLoss #ObesityCare #EvidenceBasedMedicine #HealthyLifestyle · August ...

Nov 9, 2025 View →
Once-weekly semaglutide 2.4 mg led to significant decreases in ...
Facebook

2021;doi:10.1001/jama. 2021.3224. Wadden TA, et at. JAMA. 2021;doi:10.1002/jama. 2021.1831. Wilding JPH, et al. N Engl J Med. 2021;doi ...

Oct 17, 2025 View →
Ozempic 2025: Expanding Indications and Market Challenges
News

JAMA, 325(14), pp.1414–1425. doi:10.1001/jama.2021.3224; Hendershot, C. S., Bremmer, M., et al. (2025). Once-Weekly Semaglutide for Alcohol ...

Sep 26, 2025 View →
Pfizer Nears $7.3B Acquisition of Obesity Drugmaker Metsera! Pfizer ...
Instagram

JAMA. 2021;325(14):1414–1425. DOI: 10.1001/jama.2021.3224 #Ozempic #WeightLoss #ObesityCare #EvidenceBasedMedicine #HealthyLifestyle.

Sep 22, 2025 View →
„Ozempic prieš vestuves“ arba kaip iš vaisto padaryti ... - Facebook
Facebook

JAMA, 325(14): 1414–1425. doi:10.1001/jama.2021.3224 Wilding JPH, Garvey WT, Batterham RL, et al. (SELECT Trial Investigators). (2023) ...

Sep 15, 2025 View →
Hablemos de OZEMPIC y WEGOVY . Su uso se ha ... - Instagram
Instagram

JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224. Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen ...

Aug 27, 2025 View →
Cheers to 2025 Gratitud - Instagram
Instagram

doi:10.1001/jama.2021.3224. Aronne LJ, et al. JAMA. 2024;331:38–48. doi:10.1001/jama.2023.24945. View all 11 comments · dra.luisacalderon.

Jan 1, 2025 View →
Health Canada approved semaglutide 2.4mg (Wegovy) to reduce ...
Facebook

2021;doi:10.1001/jama. 2021.3224. Wadden TA, et at. JAMA. 2021;doi:10.1002/jama. 2021.1831. Wilding JPH, et al. N Engl J Med. 2021;doi ...

Dec 2, 2024 View →
Beber o suco ou comer a fruta? Qual é o melhor? Essa é ... - Instagram
Instagram

JAMA. 2021;325(14):1414–1425. doi:10.1001/jama.2021.3224. October 21, 2025 · leidianeduarte.nutri's profile picture · leidianeduarte.nutri. •.

Sep 13, 2024 View →
TSB | Ozempic, the drug used to treat type-diabetes and obesity ...
Instagram

JAMA. 2021;325(14):1414–1425. DOI: 10.1001/jama.2021.3224 #Ozempic #WeightLoss #ObesityCare #EvidenceBasedMedicine #HealthyLifestyle · 6 ...

Aug 31, 2024 View →
Unidos Salvando Vidas” ‍⚕️ Más por mis pacientes. - Instagram
Instagram

doi:10.1001/jama.2021.3224. Aronne LJ, et al. JAMA. 2024;331:38–48. doi:10.1001/jama.2023.24945. View all 11 comments · dra.luisacalderon.

Jun 14, 2024 View →
Effectiveness and durability of common weight loss methods
News

JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224. 4. Aronne, Louis J.; Sattar, Naveed; Horn, Deborah B.; Bays, Harold E.; Wharton ...

Jun 13, 2024 View →
Medanta - Facebook
Facebook

2021;doi:10.1001/jama. 2021.3224. Wadden TA, et at. JAMA. 2021;doi:10.1002/jama. 2021.1831. Wilding JPH, et al. N Engl J Med. 2021;doi ...

Apr 23, 2024 View →
#acc24 #acccvt #accmember | Christopher Roe, MBA, DNP, APRN ...
LinkedIn

... how we manage blood pressure and lipids. ⚖ #ACCCVT #ACCMember Rubino, et al. (2021). doi:10.1001/jama.2021.3224.

Apr 6, 2024 View →
Una noche especial de comparsas . @clubvalleduparoficial
Instagram

doi:10.1001/jama.2021.3224. Aronne LJ, et al. JAMA. 2024;331:38–48. doi:10.1001/jama.2023.24945. View all 11 comments · dra.luisacalderon.

Feb 4, 2024 View →
Wegovy: A Breakthrough in Weight Loss? - News-Medical
News

doi:10.1001/jama.2021.3224. https://jamanetwork.com/journals/jama/fullarticle/2777886. Amaro, A. et al. (2022). Efficacy and safety of ...

Sep 25, 2023 View →
Damary Berenice Vásquez Gutierrez - Facebook
Facebook

doi: 10.1001/jama.2021.3224 Aronne LJ, et al. JAMA. 2024;331:38–48. doi: 10.1001/jama.2023.24945 MENSAJE ANCLADO Esta historia está ...

Sep 24, 2023 View →
Feito por @citius_consultoria_esportiva Será que ainda é novidade ...
Facebook

JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224 Locatelli JC, et al. Incretin-Based Weight Loss Pharmacotherapy: Can Resistance ...

Sep 24, 2023 View →
Além da Farmacologia - Facebook
Facebook

2021.3224](https://doi. org/10.1001/jama.2021.3224) Deixe um comentário sobre a sua opinião sobre esse estudo ou esse medicamento. E ...

Jan 13, 2023 View →
FDA approves semaglutide 2.4mg, a once-weekly subcutaneous ...
Facebook

2021;doi:10.1001/jama. 2021.3224. Wadden TA, et at. JAMA. 2021;doi:10.1002/jama. 2021.1831. Wilding JPH, et al. N Engl J Med. 2021;doi ...

Jan 3, 2023 View →
Shifting the scales: a promising new era for weight-loss drugs
News

JAMA 2021;325:1414–25. doi:10.1001/jama.2021.3224. 11. WegovyTM demonstrated significant and sustained weight loss in two-year study in adults ...

Jun 9, 2022 View →
Escrito por @vitormnovaes; Não chegar a falha muscular é melhor ...
Facebook

JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224 Locatelli JC, et al. Incretin-Based Weight Loss Pharmacotherapy: Can Resistance ...

Apr 12, 2022 View →
Feito por @renato_bianchini A gente já falou muitas vezes aqui ...
Facebook

JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224 Locatelli JC, et al. Incretin-Based Weight Loss Pharmacotherapy: Can Resistance ...

Mar 5, 2022 View →
hi, 33 - Instagram
Instagram

JAMA, 2021 doi.org/10.1001/jama.2021.3224 6. Тренировки и лираглутид (карточка 7) Jensen S.B.K. et al. Healthy weight loss maintenance with ...

Feb 9, 2022 View →
A new era': How semaglutide could change the obesity treatment ...
Facebook

2021;doi:10.1001/jama. 2021.3224. Wadden TA, et at. JAMA. 2021;doi:10.1002/jama. 2021.1831. Wilding JPH, et al. N Engl J Med. 2021;doi ...

Oct 23, 2021 View →
Semaglutide is a Promising Drug Treatment for Chronic Weight ...
News

... JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224; Wegovy. [Package insert]. The Food and Drug Administration. Novo Nordisk. 2021. Pi ...

Aug 17, 2021 View →
[Article] Effect of Continued Weekly Subcutaneous Semaglutide vs ...
Reddit

DOI: 10.1001/jama.2021.3224 JAMA article link unavailable via sci-hub etc unfortunately Effect of Continued Weekly Subcutaneous Semaglutide ...

May 6, 2021 View →
Semaglutyd w leczeniu nadwagi i otyłości u dorosłych pacjentów ...
News

Źródło: doi:10.1001/jama.2021.3224. Semaglutyd w leczeniu nadwagi i otyłości u dorosłych pacjentów bez cukrzycy. 123RF. W badaniu o akronimie ...

Apr 15, 2021 View →
E aí, qual dessas é a maior mentira da prescrição de treinos? Tem ...
Facebook

JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224 Locatelli JC, et al. Incretin-Based Weight Loss Pharmacotherapy: Can Resistance ...

Apr 1, 2021 View →
Maintenance Semaglutide Keeps Shedding the Pounds
News

... semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity" JAMA 2021; DOI: 10.1001/jama.2021.3224. 1. 1 Comment.

Mar 23, 2021 View →
Escrito por @renato_bianchini⁣ ⁣ Infelizmente devido a praticidade ...
Facebook

JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224 Locatelli JC, et al. Incretin- Based Weight Loss Pharmacotherapy: Can Resistance ...

May 5, 2020 View →
Citius: - Feito por @renato_bianchini⁣ ⁣ Por incrível ...
Facebook

JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224 Locatelli JC, et al. Incretin-Based Weight Loss Pharmacotherapy: Can Resistance ...

Mar 13, 2020 View →
Lucky Ý. Sëvėn added a new photo. - Facebook
Facebook

JAMA. 2021. https://doi. org/10.1001/jama.2021.3224 4. Ghusn W et al. Weight loss outcomes with semaglutide. JAMA Netw Open. 2022. https ...

Jan 9, 2020 View →
Citius: - Facebook
Facebook

JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224 Locatelli JC, et al. Incretin-Based Weight Loss Pharmacotherapy: Can Resistance ...

Nov 24, 2019 View →
Medicina - Facebook
Facebook

JAMA. 2021;325(14): 1414-1425. doi:10.1001/jama.2021.3224 Shi Q, Wang Y, Hao Q, et al. Pharmacotherapy for adults with overweight and obesity: a ...

Oct 24, 2019 View →
Escrito por @vitormnovaes;⁣ ⁣ Este é um modelo de periodização ...
Facebook

JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224 Locatelli JC, et al. Incretin-Based Weight Loss Pharmacotherapy: Can Resistance ...

Jun 12, 2019 View →
New treatment for obesity now available in Qatar Novo Nordisk has ...
Facebook

2021;doi:10.1001/jama. 2021.3224. Wadden TA, et at. JAMA. 2021;doi:10.1002/jama. 2021.1831. Wilding JPH, et al. N Engl J Med. 2021;doi ...

Oct 22, 2017 View →
Citius: Exercício, Nutrição e Resultado - A asma ... - Facebook
Facebook

JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224 Locatelli JC, et al. Incretin-Based Weight Loss Pharmacotherapy: Can Resistance ...

May 10, 2016 View →